{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:13:14Z","timestamp":1791267194070,"version":"4.1.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cutaneous and Ocular Toxicology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1080\/15569527.2024.2402408","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T08:26:17Z","timestamp":1726129577000},"page":"293-298","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["A national analysis of systemic adverse events of beta-blockers used for glaucoma therapy"],"prefix":"10.1080","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5132-3956","authenticated-orcid":false,"given":"Owais M.","family":"Aftab","sequence":"first","affiliation":[{"name":"Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Khan","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshun","family":"Sangani","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert S.","family":"Khouri","sequence":"additional","affiliation":[{"name":"Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.01.004"},{"issue":"5","key":"e_1_3_4_3_1","first-page":"508","article-title":"[Glaucoma treatment]","volume":"66","author":"Bluwol E.","year":"2016","unstructured":"Bluwol E. [Glaucoma treatment]. Rev Prat. 2016;66(5):508\u2013513.","journal-title":"Rev Prat"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199202030-00005"},{"issue":"6","key":"e_1_3_4_5_1","first-page":"451","article-title":"Comparison of ophthalmic beta-blocking agents","volume":"6","author":"Lesar TS.","year":"1987","unstructured":"Lesar TS. Comparison of ophthalmic beta-blocking agents. Clin Pharm. 1987;6(6):451\u2013463.","journal-title":"Clin Pharm"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(83)90140-6"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1989.tb00483.x"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200724060-00007"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.2019.1486"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90532-5"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocv063"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14868"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2113"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.966331"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.5892"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-5-481"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225060-00001"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/UPJ.0000000000000497"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.01.020"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2024.04.006"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(80)35215-9"},{"issue":"9","key":"e_1_3_4_25_1","first-page":"929","article-title":"Beta-blocker therapy and the risk of anaphylaxis","volume":"136","author":"Toogood JH.","year":"1987","unstructured":"Toogood JH. Beta-blocker therapy and the risk of anaphylaxis. CMAJ. 1987;136(9):929\u2013933.","journal-title":"CMAJ"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.172"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(00)00611-5"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00771-y"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204086"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-2877-x"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.5346"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.0608"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0875-7"},{"key":"e_1_3_4_34_1","volume-title":"ClinCalc DrugStats database","author":"AHRQ","year":"2020","unstructured":"AHRQ. ClinCalc DrugStats database. Rockville, MD: Agency for Healthcare Research and Quality 2020."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.08.041"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.02.022"}],"container-title":["Cutaneous and Ocular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15569527.2024.2402408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:59:09Z","timestamp":1733140749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15569527.2024.2402408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1080\/15569527.2024.2402408"],"URL":"https:\/\/doi.org\/10.1080\/15569527.2024.2402408","relation":{},"ISSN":["1556-9527","1556-9535"],"issn-type":[{"value":"1556-9527","type":"print"},{"value":"1556-9535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icot20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icot20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}